Medicines Distribution Consents




NEW ZEALAND GAZETTE

No. 107


Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Budesonide 50 µg/dose, 100 µg/dose, 200 µg/dose Inhaler, aerosol, metered Ingelheim Pharmaceuticals Pty Limited, Pretoria, South Africa Inflammide
Piperacillin sodium 1.04 g, 2.08 g, 4.16 g equivalent to 1 g, 2 g, 4 g piperacillin Injection, powder Istituto Biochimico Italiano, Aprilia (LT), Italy Piperacillin

Dated this 28th day of July 1998.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go5419


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Sodium valproate 100 mg Tablet Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom Epilim 100
Sodium valproate 200 mg, 500 mg Tablets, modified release Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom Crushable Epilim EC
Sodium valproate 40 mg/mL Solution, oral Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom; Universal Products (Lytham) Manufacturing Limited, Greenhalgh, Kirkham, Preston, Lancashire, United Kingdom and Sanofi Winthrop Industrie, Colomiers, France Epilim Liquid
Sodium valproate 40 mg/mL Syrup Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom; Universal Products (Lytham) Manufacturing Limited, Greenhalgh, Kirkham, Preston, Lancashire, United Kingdom and Sanofi Winthrop Industrie, Colomiers, France Epilim Syrup
Oestradiol 1.6 mg (25 µg/24 hours), 3.2 mg (50 µg/24 hours), 4.8 mg (75 µg/24 hours), 6.4 mg (100 µg/24 hours) Transdermal patch Lohmann Therapie Systeme GmbH & Co KG., Andernach, Germany Evorel
Omeprazole 10 mg, 20 mg Capsules Astra Pharmaceutical Production AB., Södertälje, Sweden Losec
Enalapril maleate 2.5 mg, 5 mg, 10 mg, 20 mg Wafers R P Scherer Limited, Blagrove, Swindon, Wiltshire, United Kingdom Renitec RPD
Somatropin 24 IU Injection, powder with diluent Serono Pharma SpA., Bari, Italy; Diluent (cartridge): Laboratoire Aguettant, Champagne, France; Diluent (vial): Laboratoires Serono SA., Aubonne, Switzerland Saizen 24
Paclitaxel 6 mg/mL Infusion, concentrate Bristol Caribbean Inc., Mayaguez, Puerto Rico Taxol
Interferon alpha 1.3 MIU/mL, 10 MIU/mL Injection, solution Glaxo Wellcome Research & Development, Beckenham, Kent, United Kingdom Wellferon


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1998, No 107


NZLII PDF NZ Gazette 1998, No 107





✨ LLM interpretation of page content

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
28 July 1998
Medicines, Distribution, Consent, New Medicine, Budesonide, Piperacillin
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
28 July 1998
Medicines, Distribution, Consent, Changed Medicines, Sodium valproate, Oestradiol, Omeprazole, Enalapril maleate, Somatropin, Paclitaxel, Interferon alpha
  • G. R. Boyd, Chief Advisor, Regulation and Safety